Related Experiment Video
Updated: Nov 17, 2025

05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
359
Palmoplantar Involvement in Leprosy: A Clinicopathological Study
Garima Dabas1, Tarun Narang1, Sunil Dogra1
11Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
The American Journal of Tropical Medicine and Hygiene
|February 16, 2021
Summary
Palmoplantar involvement in leprosy, though rare, is often misdiagnosed. This condition increases the risk of lepra reactions and disabilities, highlighting the need for increased clinical suspicion.
Area of Science:
- Dermatology
- Infectious Diseases
- Public Health
Background:
- Palmoplantar involvement in leprosy is infrequently documented and prone to misdiagnosis.
- Early identification is crucial for effective management and preventing complications.
Purpose of the Study:
- To analyze the prevalence, clinical presentation, and outcomes of palmoplantar involvement in leprosy patients.
- To assess the association between palmoplantar involvement and lepra reactions or disabilities.
Main Methods:
- Retrospective analysis of a leprosy clinic database from 2015 to 2018.
- Inclusion of 520 leprosy patients, with detailed examination of those exhibiting palmoplantar symptoms.
Main Results:
- Palmoplantar involvement was observed in 9.4% (49/520) of patients.
- Isolated palm involvement was most common (53.1%), followed by combined palm and sole (24.5%) and sole-only (22.4%) involvement.
- Patients with palmoplantar involvement showed a significantly higher incidence of lepra reactions and disabilities (P < 0.0001).
Conclusions:
- Palmoplantar involvement in leprosy, while uncommon, is a significant indicator of increased risk for reactions and disabilities.
- Maintaining a high index of suspicion for palmoplantar manifestations is essential to reduce leprosy misdiagnosis and improve patient outcomes.
Related Concept Videos
Pulmonary Tuberculosis I
498
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
498
Pulmonary Tuberculosis III
605
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
605
Pulmonary Tuberculosis II
869
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
869

